Skip to main content
Clinical Trials/JPRN-UMIN000013109
JPRN-UMIN000013109Completed未知

Peri-operative chemotherapy with intraperitoneal and intravenous Paclitaxel plus TS-1 for serosa positive gastric cancer patients - GAPS study

Intraperitoneal chemotherapy study group0 sites50 target enrollmentStarted: February 21, 2014Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to 75years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (i)The occurrence of simultaneous or metachronous (within 5 years) double cancers, with the exception of intramucosal tumor that is curable with local therapy (ii)A history of severe drug hypersensitivity (iii)The presence of active bacterial or fungal infection, and a body temperature over 38 temperature. (iv)Pregnancy or lactation in women of childbearing potential (v)Men who wish the partners pregnancy (vi)The presence of unstable angina, heart failure or a history of myocardial infarction within 6 months (vii)Patients requiring systemic steroid medication (viii)Patients requiring the administration of phenytoin or warfarin potassium (ix)The presence to peptic ulcer or bleeding (x)The presence of severe diarrhea (xi)The presence of antigen-positive serum HBs and/or antibody positive serum HVC (xii)The presence of uncontrollable intestinal paralysis, interstitial pneumonitis or ischemic heart disease (xiii)Patients determined to be inappropriate for this study

Investigators

Sponsor
Intraperitoneal chemotherapy study group

Similar Trials